Akt Cancer Research Results
Akt, PKB-Protein kinase B: Click to Expand ⟱
| Source: HalifaxProj(inhibit) |
| Type: |
Akt1 is involved in cellular survival pathways, by inhibiting apoptotic processes; Akt2 is an important signaling molecule in the insulin signaling pathway. It is required to induce glucose transport.
Inhibitors:
-Curcumin: downregulate AKT phosphorylation and signaling.
-Resveratrol
-Quercetin: inhibit the PI3K/AKT pathway.
-Epigallocatechin Gallate (EGCG)
-Luteolin and Apigenin: inhibit AKT phosphorylation
|
Diabetic, Diabetic: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Diabetic, |
NA |
|
|
|
ROS↑, eff↑, other↝, DNAdam↑, EPR↑, eff↑, eff↑, TumMeta↓, angioG↓, *Bacteria↓, *eff↑, *AntiViral↑, *AntiFungal↑, eff↑, eff↑, TumCP↓, tumCV↓, P53↝, HIF-1↓, TumCCA↑, lipid-P↑, ATP↓, Cyt‑c↑, MMPs↓, PI3K↓, Akt↓, *Wound Healing↑, *Inflam↓, *Bone Healing↑, *glucose↓, *AntiDiabetic↑, *BBB↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Diabetic, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*neuroP↑, *Inflam↓, *antiOx↑, *cardioP↑, *NRF2↑, *AMPK↑, *SOD↑, *Catalase↑, *GSH↑, *GPx↑, *ROS↓, *TNF-α↓, *IL6↓, *NF-kB↓, *COX2↓, *glucose↓, *TRPC1↓, *Ca+2↓, *HO-1↑, *NF-kB↓, *PPARα↝, *Hif1a↓, *JNK↓, *BP↓, *AntiDiabetic↑, *hepatoP↑, *TLR4↓, *NRF2↑, *Casp↓, *neuroP↑, *Aβ↓, *LDH↓, *MDA↓, *memory↑, *AChE↓, *eff↑, EMT↝, N-cadherin↓, E-cadherin↑, TumCCA↑, ROS↑, p‑P53↑, HO-1↑, NRF2↑, ChemoSen↑, mtDam↑, Casp3↑, Casp9↑, PARP↑, Bax:Bcl2↑, TumCG↓, cycD1/CCND1↓, cMyc↓, CDK2↓, mitResp↓, Glycolysis↓, Hif1a↓, PCNA↓, p‑GSK‐3β↓, VEGF↓, PI3K↓, Akt↓, mTOR↓, OS↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Diabetic, |
NA |
|
|
|
*MAPK↓, *neuroP↑, *ROS↓, *Akt↓, *PI3K↓, *IL6↓, *TNF-α↓, *VEGF↓, *EGFR↓, *Casp3↓, *Bcl-2↓, *IL1β↓,
*p‑PDK1↓, *p‑Akt↓, *Hif1a↓, *GLUT1↓,
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
HO-1↑, 1, lipid-P↑, 1, NRF2↑, 1, ROS↑, 2,
Mitochondria & Bioenergetics ⓘ
ATP↓, 1, mitResp↓, 1, mtDam↑, 1,
Core Metabolism/Glycolysis ⓘ
cMyc↓, 1, Glycolysis↓, 1,
Cell Death ⓘ
Akt↓, 2, Bax:Bcl2↑, 1, Casp3↑, 1, Casp9↑, 1, Cyt‑c↑, 1,
Transcription & Epigenetics ⓘ
other↝, 1, tumCV↓, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1, P53↝, 1, p‑P53↑, 1, PARP↑, 1, PCNA↓, 1,
Cell Cycle & Senescence ⓘ
CDK2↓, 1, cycD1/CCND1↓, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State ⓘ
EMT↝, 1, p‑GSK‐3β↓, 1, mTOR↓, 1, PI3K↓, 2, TumCG↓, 1,
Migration ⓘ
E-cadherin↑, 1, MMPs↓, 1, N-cadherin↓, 1, TumCP↓, 1, TumMeta↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, EPR↑, 1, HIF-1↓, 1, Hif1a↓, 1, VEGF↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1, eff↑, 5,
Functional Outcomes ⓘ
OS↑, 1,
Total Targets: 42
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, Catalase↑, 1, GPx↑, 1, GSH↑, 1, HO-1↑, 1, MDA↓, 1, NRF2↑, 2, ROS↓, 2, SOD↑, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 1, glucose↓, 2, LDH↓, 1, p‑PDK1↓, 1, PPARα↝, 1,
Cell Death ⓘ
Akt↓, 1, p‑Akt↓, 1, Bcl-2↓, 1, Casp↓, 1, Casp3↓, 1, JNK↓, 1, MAPK↓, 1,
Proliferation, Differentiation & Cell State ⓘ
PI3K↓, 1,
Migration ⓘ
Ca+2↓, 1, TRPC1↓, 1,
Angiogenesis & Vasculature ⓘ
EGFR↓, 1, Hif1a↓, 2, VEGF↓, 1,
Barriers & Transport ⓘ
BBB↑, 1, GLUT1↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, IL1β↓, 1, IL6↓, 2, Inflam↓, 2, NF-kB↓, 2, TLR4↓, 1, TNF-α↓, 2,
Synaptic & Neurotransmission ⓘ
AChE↓, 1,
Protein Aggregation ⓘ
Aβ↓, 1,
Drug Metabolism & Resistance ⓘ
eff↑, 2,
Clinical Biomarkers ⓘ
BP↓, 1, EGFR↓, 1, IL6↓, 2, LDH↓, 1,
Functional Outcomes ⓘ
AntiDiabetic↑, 2, Bone Healing↑, 1, cardioP↑, 1, hepatoP↑, 1, memory↑, 1, neuroP↑, 3, Wound Healing↑, 1,
Infection & Microbiome ⓘ
AntiFungal↑, 1, AntiViral↑, 1, Bacteria↓, 1,
Total Targets: 53
Scientific Paper Hit Count for: Akt, PKB-Protein kinase B
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:61 Cells:% prod#:% Target#:4 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page